finasteride and Invasiveness, Neoplasm

finasteride has been researched along with Invasiveness, Neoplasm in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fradet, V; Fradet, Y; Lacombe, L; Lodde, M; McMartin, C; Toren, P1
Almeida, R; Deffune, E; Delella, FK; Fávaro, WJ; Felisbino, SL; Lacorte, LM; Moroz, A1
Logothetis, CJ; Schellhammer, PF1
Coltman, CA; Darke, AK; Ford, LG; Goodman, PJ; La Rosa, FG; Lucia, MS; Parnes, HL; Thompson, IM1
Damjanoski, I; Küfer, R; Müller, J; Rinnab, L; Schnöller, TJ1

Trials

1 trial(s) available for finasteride and Invasiveness, Neoplasm

ArticleYear
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.
    Cancer prevention research (Philadelphia, Pa.), 2008, Volume: 1, Issue:3

    Topics: Aged; Antineoplastic Agents; Biopsy; Chemoprevention; Early Detection of Cancer; Finasteride; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Organ Size; Placebos; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Treatment Outcome; Tumor Burden

2008

Other Studies

4 other study(ies) available for finasteride and Invasiveness, Neoplasm

ArticleYear
Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?
    Clinical genitourinary cancer, 2019, Volume: 17, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Aged; Carcinoma, Transitional Cell; Cystectomy; Dutasteride; Finasteride; Humans; Logistic Models; Male; Margins of Excision; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms

2019
Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: 5-alpha Reductase Inhibitors; Cell Line, Tumor; Cell Survival; Down-Regulation; Finasteride; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hepatitis A Virus Cellular Receptor 1; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Glycoproteins; Neoplasm Invasiveness; Neoplasm Proteins; Prostatic Neoplasms; Receptors, Virus; Tissue Inhibitor of Metalloproteinase-2

2013
High-grade prostate cancer and the prostate cancer prevention trial.
    Cancer prevention research (Philadelphia, Pa.), 2008, Volume: 1, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Antineoplastic Agents; Enzyme Inhibitors; Finasteride; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome; Tumor Burden

2008
[Histopathology reports of findings of prostate needle biopsies. Individual treatment].
    Der Urologe. Ausg. A, 2013, Volume: 52, Issue:2

    Topics: Adenocarcinoma; Attitude of Health Personnel; Biomarkers, Tumor; Biopsy, Needle; Cell Proliferation; Cooperative Behavior; Decision Support Techniques; Disease Progression; Finasteride; Germany; Guideline Adherence; Humans; Interdisciplinary Communication; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Palliative Care; Patient Care Planning; Phosphodiesterase 5 Inhibitors; Precision Medicine; Prognosis; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Surveys and Questionnaires

2013